Answers are grounded in this paper and cite their sources.
Muscle-invasive bladder cancer (MIBC) is distinguished by its pronounced invasiveness and unfavorable prognosis. Immunotherapy and targeted therapy have emerged as key treatment options for various types of cancer. Altered metabolism is a defining characteristic of cancer cells, and there is mounting evidence suggesting the important role of glutamine metabolism (GM) in tumor metabolism. Nevertheless, the relationship between GM and clinical outcomes, immune microenvironment, and immunotherapy in MIBC remains unknown.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: